2001 Clinical Research Licensing Pharma Companies 
Drug Discovery World
OCTOBER 16, 2023
Dr Tralau-Stewart says: “Indeed, many academic institutions have established new ways of supporting the discovery pipeline, providing tech transfer offices to support licensing, and entrepreneurship and start-up support through fundraising, accelerators, and incubators.
Drug Discovery World
OCTOBER 7, 2022
TH : Increasingly, large pharma companies need scale, agility and access to academic partnerships to succeed. This funding is distributed between funding discovery research at our core institutes, and at universities around the UK, clinical research, cancer grand challenges, and translational research. .
Expert insights. Personalized for you.
189 
Let's personalize your content